Skip to main content
Egyptian Journal of Radiology and Nuclear Medicine
Fig. 3 | Egyptian Journal of Radiology and Nuclear Medicine

Fig. 3

From: Role of [18F] FDG PET-CT in detection of COVID-19 vaccine-associated hypermetabolic lymphadenopathy (VAHL) in lymphoma patients: with serologic testing correlation

Fig. 3

A 42-year-old male patient with NHL, treated with anti-cd20 antibody rituximab 10 months prior to vaccination. After 1 year of disease-free, PET/CT reported new left axillary, supraclavicular and lower cervical LNs. Clinical data revealed that he received the 2nd dose of Pfizer-BioNTech vaccine in his left arm 6 days prior to PET/CT. A Coronal CECT and B coronal PET/CT images revealed enlarged FDG-avid left axillary, supraclavicular and lower cervical LNs, largest measures 2 cm in left axilla of 11 SUVmax

Back to article page